Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
mi
from
Lakewood, WA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Lakewood Community Dialysis Center
mi
from
Lakewood, WA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
mi
from
Appleton, WI
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Fox Valley Nephrology Partners, SC
mi
from
Appleton, WI
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
mi
from
Delafield, WI
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Purity Dialysis Centers
mi
from
Delafield, WI
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
mi
from
LaCrosse, WI
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Gundersen Lutheran
mi
from
LaCrosse, WI
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
mi
from
Oshkosh, WI
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Fox Valley Nephrology Partners, PC
mi
from
Oshkosh, WI
Click here to add this to my saved trials
New Non-invasive Methods for Real-time Monitoring of Organ Function.
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Status: Enrolling
Updated:  6/16/2016
mi
from
St. Louis, MO
New Non-invasive Methods for Real-time Monitoring of Organ Function.
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Status: Enrolling
Updated: 6/16/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated:  6/16/2016
mi
from
Rochester, MN
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 6/16/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
Tempe, AZ
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Southwest Vascular Center
mi
from
Tempe, AZ
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
San Diego, CA
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
BNMG San Diego Vascular Access Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
Plano, TX
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Dallas Nephrology Associates
mi
from
Plano, TX
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
San Antonio, TX
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
San Antonio Kidney Disease Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated:  7/11/2016
mi
from
North Chesterfield, VA
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Richmond Vascular Center
mi
from
North Chesterfield, VA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Birmingham, AL
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Loma Linda, CA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Loma Linda University Medical Center-Transplantation Institu
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Los Angeles, CA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
San Diego, CA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
California Institute of Renal Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
San Francisco, CA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Aurora, CO
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
New Haven, CT
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Yale University School of Medicine/Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Atlanta, GA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Atlanta, GA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Augusta, GA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Chicago, IL
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
The University of Chicago Hospitals
mi
from
Chicago, IL
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Iowa City, IN
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University Of Iowa Hospitals And Clinics
mi
from
Iowa City, IN
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Lexington, KY
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Portland, ME
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Maine Tranplant Program
mi
from
Portland, ME
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Springfield, MA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Detriot, MI
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Henry Ford Hospital, Transplant Institute
mi
from
Detriot, MI
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Minneapolis, MN
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Saint Louis, MO
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
New York, NY
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Recanati/Miller Transplantation Institute
mi
from
New York, NY
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
New York, NY
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Rochester, NY
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Chapel Hill, NC
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Charlotte, NC
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Durham, NC
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Philadelphia, PA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Div Of Multi-Organ Trans, Hepato-Biliary-Pancreatic Surgery
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Charleston, SC
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
MUSC
mi
from
Charleston, SC
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Nashville, TN
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Dallas, TX
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Burlington, VT
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Fairfax, VA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Inova Transplant Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Seattle, WA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Spokane, WA
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Sacred Heart Medical Ctr Providence Medical Research Ctr
mi
from
Spokane, WA
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Madison, WI
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Milwaukee, WI
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated:  7/12/2016
mi
from
Capital Federal,
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Local Institution
mi
from
Capital Federal,
Click here to add this to my saved trials
Volume,Sodium and Blood Pressure Management in HD
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated:  7/14/2016
mi
from
Ann Arbor, MI
Volume,Sodium and Blood Pressure Management in HD
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
University Dialysis Unit
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Volume,Sodium and Blood Pressure Management in HD
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated:  7/14/2016
mi
from
Livonia, MI
Volume,Sodium and Blood Pressure Management in HD
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
University of Michigan Dialyisis Unit
mi
from
Livonia, MI
Click here to add this to my saved trials
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated:  7/18/2016
mi
from
Nashville, TN
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated: 7/18/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials